Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid
Anticancer Research · 2023
DOI: 10.21873/anticanres.16636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Jr-DI Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Glycyrrhetinic Acid, Liver Neoplasms, Phenylurea Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C.
- Institute of Traditional Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.
- Department of Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.; john740604@yahoo.com.tw.
- Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
- Department of Medical Imaging and Radiologic Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
Zitieren
APA
Yang, J. D., Yueh, P. F., Liao, T. L., Chen, Y. T., Hsu, F. T., Chiang, I. T., Chang, C. M., & Wang, W. S. (2023). Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid. Anticancer Research. https://doi.org/10.21873/anticanres.16636
Vancouver
Yang JD, Yueh PF, Liao TL, Chen YT, Hsu FT, Chiang IT, et al. Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid. Anticancer Research. 2023. doi:10.21873/anticanres.16636
BibTeX
@article{Yang2023,
author = {Yang, Jr-DI and Yueh, Po-Fu and Liao, Tsai Lan and Chen, Ying-Tzu and Hsu, Fei-Ting and Chiang, I-Tsang and Chang, Ching Ming and Wang, Wei-Shu},
title = {Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16636}
}
EUVIMED